A Retrospective Analysis of Real-World Discontinuation Rates With Delayed-Release Dimethyl Fumarate in Patients With Relapsing–Remitting Multiple Sclerosis

Neurology and Therapy - United States
doi 10.1007/s40120-019-00174-3
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effectiveness of Delayed-Release Dimethyl Fumarate on Patient-Reported Outcomes and Clinical Measures in Patients With Relapsing–remitting Multiple Sclerosis in a Real-World Clinical Setting: PROTEC

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2019English

Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients With Relapsing Forms of Multiple Sclerosis (MANAGE)

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2016English

Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients With Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies

Neurology and Therapy
Neurology
2016English

Cognitive Profile of Patients With Relapsing Remitting Multiple Sclerosis

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
1999English

Budget Impact Analysis of Delayed-Release Dimethylfumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Pnd72 - Cost-Minimization Analysis of Teriflunomide and Dimethyl Fumarate for Treatment of Relapsing-Remitting Forms of Multiple Sclerosis in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis

Archives of Neurology
2005English

Real-Life Effectiveness of Natalizumab in Relapsing-Remitting Multiple Sclerosis (Rrms): A Registry Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy